BiotechTube
Home/Beam Therapeutics/Giuseppe Ciaramella, Ph.D.
GC

Giuseppe Ciaramella, Ph.D.

President

Beam Therapeutics

Therapeutic Areas

HematologyImmunology & OncologyGenetic Liver Diseases

Beam Therapeutics Pipeline

DrugIndicationPhase
BEAM-101Sickle Cell Disease / Beta-ThalassemiaPhase 1/2
BEAM-102Sickle Cell DiseasePreclinical
BEAM-201Acute Myeloid Leukemia / R/R T-ALLPhase 1/2
BEAM-301Glycogen Storage Disease Type Ia (GSDIa)Preclinical
BEAM-302Alpha-1 Antitrypsin Deficiency (AATD)Phase 1/2

Leadership Team at Beam Therapeutics

JE
John Evans
Chief Executive Officer and Board Member
AS
Amy Simon, M.D.
Chief Medical Officer
DL
David Liu
Scientific Founder
FZ
Feng Zhang
Scientific Founder
JK
J. Keith Joung
Scientific Founder
View full Beam Therapeutics profile